GTBP 8-K 2026-09-21

GT Biopharma, Inc. (GTBP) 8-K dated 2026-09-21 — accession 0001493152-26-043562. This URL is the filing, not the GTBP hub.

GT Biopharma, Inc. (GTBP) is a biotechnology company listed on NASDAQ.

GT Biopharma, Inc. filed a 8-K on 2026-09-21. Accession 0001493152-26-043562.

Cached items: 1.01, 3.02, 3.03, 5.03, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported GTBP revenue for 2020-12-31 was $0. Net income was -$28.3M. GTBP currently screens at market cap $17.4M.

Not investment advice. The GTBP SEC hub lists recent forms. The stock page is the research view.